Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Nvidia invests $1.5 billion in SB Energy to support Ohio AI data center campus

Nvidia invests $1.5 billion in SB Energy to support Ohio AI data center campus

ReutersReuters2026/08/17 12:42
  • Nvidia secured land, power, and shell capacity at SB Energy’s PORTS-Pike campus in Ohio for NVIDIA compute.
  • The site will exclusively host NVIDIA AI compute infrastructure, with SB Energy building, owning, and operating the data center under a 20-year lease to OpenAI.
  • Credit support covers an initial 4.25 IT-GW, with an option to take the remaining 3.75 IT-GW.
  • OpenAI is set as the customer for 8 IT-GW of AI factory capacity, with phased availability expected to start in 2028.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nvidia Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001045810-26-000069), on August 17, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AstraZeneca (AZN.US) / Daiichi Sankyo ADC first-line lung cancer phase III study succeeds

On August 17, AstraZeneca (AZN.US) and Daiichi Sankyo jointly announced that the Phase III DESTINY-Lung04 study of Enhertu (trastuzumab deruxtecan) as a monotherapy for first-line treatment of non-small cell lung cancer (NSCLC) has achieved highly positive results.

智通财经2026/08/17 12:56
AstraZeneca (AZN.US) / Daiichi Sankyo ADC first-line lung cancer phase III study succeeds